Clinical trial
Phase II Trial of O6Benzylguanine and BCNU in Patients With Colon and Rectal Carcinoma
NCT00005981 is registered in ClinicalTrials.gov with Case Comprehensive Cancer Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase II Trial of O6Benzylguanine and BCNU in Patients With Colon and Rectal Carcinoma
- Lead sponsor
- Case Comprehensive Cancer Center
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- June 30, 2000
- Completion date
- November 30, 2003
- Enrollment
- 13 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
colorectal cancer